Tianjin Norland Biotech Co., Ltd.

Tianjin Norland Biotech Co., Ltd. uses CIF terms, which means the buyer pays for shipping and insurance once the goods are loaded at Tianjin Port (Xingang), China. This shifts the risk and cost to the buyer after shipment, making it easier to manage logistics. Accepting USD simplifies international payments, especially for buyers in North America or Europe. Using Tianjin Port gives access to a major hub with strong container traffic and reliable freight connections. The payment method being 'Other' suggests it may not be standard — buyers should confirm terms to avoid unexpected costs or delays. Tianjin Norland Biotech Co., Ltd. has a gross revenue range of USD 5-10 million, which is typical for mid-sized biotech suppliers in China. Without specified quality certifications, buyers should verify compliance with industry standards before placing large orders. The lack of data on headcount and inquiry response time makes it harder to assess operational scale and customer service responsiveness — a key factor in long-term trade relationships.